Content by GE Healthcare Life Sciences
Innovate UK-funded project supports development of scalable, cost effective production of regenerative medicines
Swedish biotech BioLamina relies on Testa Center to expand
GE Healthcare Life Sciences introduces Biacore 8K+, an eight-needle high-sensitivity surface plasmon resonance (SPR) system
GE Healthcare Life Sciences is increasing the annual production capacity of powdered cell culture media by tenfold in its facility in Pasching, Austria
Many of the cell therapy manufacturing process steps remain largely disconnected and require a human operator to manually transfer cells from step to step
VIA Thaw CB1000 offers automated, dry thawing of cryo-bags to address key cell therapy challenges
New 2500HS and 6500HS systems provide a complete HCA solution
Partnership expands GE’s start-to-finish offering for cost efficient manufacture of biopharmaceuticals
Companies combine expertise to produce cytomegalovirus vaccine candidates.
Images to light up Times Square, New York; celebrating science, art and discovery.
GE to expand in fast-growing Life Sciences sectors; extends bioprocessing manufacturing footprint in Asia, the Americas and Europe.